SCHEMBL891743

SCHEMBL891743

C=C1[C@H](O)C[C@@H]2C[C@H]1C2(C)C

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14484474 1.00 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
SCHEMBL296319 1.00 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
Rel-Menthone SCHEMBL3965684 0.76 EP300 (0.30)
SCHEMBL5186015 0.75 MEN1 (0.61)
3-Amino-Beta-Pinene SCHEMBL4272806 0.74 MAPK1 (0.41) TSHRMAPK1
SCHEMBL14497138 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL19621396 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL12812311 0.74 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
SCHEMBL19621525 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL14463118 0.71 TSHR (0.32) TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023187598-A1 COMPOSITIONS AND METHODS BIBLICAL LANDS LTD (IL) 2023-10-05 WO claimed
EP-4229639-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS Global Biopharma, Inc. (CA) 2023-08-23 EP claimed
WO-2022081889-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS GLOBAL BIOPHARMA, INC. (CA) 2022-04-21 WO claimed
US-20190167578-A1 Transmucosal Delivery of Terpenes Via Edible Film Sanders, Daniel Carew (US) 2019-06-06 US claimed
EP-2820958-B1 COMPOSITION OF LEMON PEEL ESSENTIAL OIL AS A GROWTH PROMOTER IN THE POULTRY INDUSTRY UNIV PERUANA CAYETANO HEREDIA (PE) 2018-10-24 EP claimed
US-20150119457-A1 ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY SAN FERNANDO S.A. (PE) 2015-04-30 US claimed
EP-2820958-A1 COMPOSITION OF LEMON PEEL ESSENTIAL OIL AS A GROWTH PROMOTER IN THE POULTRY INDUSTRY Universidad Peruana Cayetano Heredia (PE) 2015-01-07 EP claimed
US-20120128648-A1 Novel Biopesticide Compositions And Method For Isolation And Characterization Of Same THE ENERGY AND RESOURCES INSTITUTE (TERI) (IN) 2012-05-24 US claimed
US-20110003317-A1 METHODS OF SCREENING COMPOUNDS FOR INSECT-CONTROL ACTIVITY INVOLVING THE TYRAMINE RECEPTOR TYRATECH, INC. (US) 2011-01-06 US claimed
US-20090232918-A1 COMPOSITIONS AND METHODS FOR CONTROLLING INSECTS TYRATECH, INC. (US) 2009-09-17 US claimed
EP-1509181-A1 PERSONAL CARE ARTICLE AND METHOD FOR INHIBITING ATTACHMENT OF YEAST TO SKIN Kimberly-Clark Worldwide, Inc. (US) 2005-03-02 EP claimed
US-20040092583-A1 Treatment for inhibiting neoplastic lesions SHANAHAN-PRENDERGAST ELIZABETH (IE) 2004-05-13 US claimed
WO-2003101356-A1 PERSONAL CARE ARTICLE AND METHOD FOR INHIBITING ATTACHMENT OF YEAST TO SKIN KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-12-11 WO claimed
US-20030224034-A1 Personal care article and method for inhibiting attachment of yeast to skin KIMBERLY-CLARK WORLDWIDE, INC. 2003-12-04 US claimed
JP-63030409-A None JP disclosed
EP-4736863-A1 NOVEL MENTHOL-EUCALYPTUS OIL ANTITUSSIVE SPRAY AND USE THEREOF Sino-Shine Biopharmaceutical Co., Ltd (CN) 2026-05-06 EP disclosed
US-20260101926-A1 VAPORIZING DEVICE MINSKOFF NOAH MARK (US) 2026-04-16 US disclosed
JP-S6330409-A AGENT FOR INHIBITING GROWTH OF CARIOGENIC BACTERIA TAIYO KORYO KK 1988-02-09 JP disclosed
EP-0190449-A1 Additive-containing paints OECE Industrie Chimiche Spa (IT) 1986-08-13 EP disclosed
US-4289917-A BASIC CATALYSTS FOR REACTIONS INVOLVING ABSTRACTION OF A PROTON SCM CORPORATION (US) 1981-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260101926-A1 VAPORIZING DEVICE SARAF, HSF1, TFPI TSHR 595/4885MAPK1 2730/4885KDM4E 4414/4885
US-20040092583-A1 Treatment for inhibiting neoplastic lesions VHL, IDH2, AIFM2 TSHR 4119/4885MAPK1 3041/4885KDM4E 2664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.